Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Conditions

• Epstein-Barr Virus (EBV) Infections
• Lymphoproliferative Disorders
• EBV+ Associated Lymphoma
• EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
• Epstein-Barr Viremia
• Lymphoma, AIDS-related
• Epstein-Barr Virus-associated Lymphoproliferative Disease (EBV+ LPD) With Primary Immunodeficiency (PID)
• Leiomyosarcoma (LMS)
• Nasopharyngeal Carcinoma (NPC)
• Epstein-Barr Virus-associated Lymphoproliferative Disease (EBV+ LPD) With Acquired Immunodeficiency (AID)
• Solid Organ Transplant Complications
• Stem Cell Transplant Complications

Interventions

• BIOLOGICAL: tabelecleucel

Sponsor

Atara Biotherapeutics